Compare BGC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGC | INSP |
|---|---|---|
| Founded | 1945 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 1999 | 2018 |
| Metric | BGC | INSP |
|---|---|---|
| Price | $9.09 | $95.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 17 |
| Target Price | $14.50 | ★ $137.63 |
| AVG Volume (30 Days) | ★ 2.4M | 1.9M |
| Earning Date | 02-13-2026 | 02-09-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ 36.46 | 34.77 |
| EPS | 0.33 | ★ 1.48 |
| Revenue | ★ $2,640,884,000.00 | $882,622,000.00 |
| Revenue This Year | $36.34 | $15.00 |
| Revenue Next Year | $11.45 | $11.24 |
| P/E Ratio | ★ $27.53 | $64.67 |
| Revenue Growth | ★ 24.59 | 16.81 |
| 52 Week Low | $7.24 | $70.77 |
| 52 Week High | $10.96 | $216.01 |
| Indicator | BGC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 38.00 |
| Support Level | $8.89 | $93.05 |
| Resistance Level | $9.13 | $97.10 |
| Average True Range (ATR) | 0.17 | 7.05 |
| MACD | 0.04 | -5.53 |
| Stochastic Oscillator | 89.29 | 9.20 |
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.